Could your genes raise lung cancer risk? new study investigates
NCT ID NCT06181812
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find how often inherited gene changes occur in Mexican patients with a type of lung cancer called adenocarcinoma. Researchers will collect blood samples from 332 participants to look for these gene changes and see if they affect survival or treatment options. The study does not offer a treatment but helps understand genetic risks in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional de Cancerología
RECRUITINGMexico City, Mexico City, 14080, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••